HIGHLIGHTS
- who: Anastasia Ushtanit and colleagues from the Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia have published the article: Perchlozone Resistance in Clinical Isolates ofMycobacterium tuberculosis, in the Journal: Antibiotics 2023, 12, x FOR PEER REVIEW of 12/Dec/2022
- what: In this study, clinical isolates from 22 patients were analyzed. The authors showed the cross-resistance between ethionamide and perchlozone in primary non-exposed to perchlozone M. tuberculosis clinical isolates.
SUMMARY
The emergence of drug-resistant tuberculosis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.